| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2826 | 2018 |
| Apalutamide for metastatic, castration-sensitive prostate cancer KN Chi, N Agarwal, A Bjartell, BH Chung, AJ Pereira de Santana Gomes, ... New England Journal of Medicine 381 (1), 13-24, 2019 | 1247 | 2019 |
| Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature JJ Fütterer, A Briganti, P De Visschere, M Emberton, G Giannarini, ... European urology 68 (6), 1045-1053, 2015 | 888 | 2015 |
| Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review CM Moore, NL Robertson, N Arsanious, T Middleton, A Villers, L Klotz, ... European urology 63 (1), 125-140, 2013 | 677 | 2013 |
| Complications after systematic, random, and image-guided prostate biopsy M Borghesi, H Ahmed, R Nam, E Schaeffer, R Schiavina, S Taneja, ... European urology 71 (3), 353-365, 2017 | 512 | 2017 |
| Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ... European urology 64 (4), 544-552, 2013 | 468 | 2013 |
| A prospective, blinded comparison of magnetic resonance (MR) imaging–ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial JS Wysock, AB Rosenkrantz, WC Huang, MD Stifelman, H Lepor, ... European urology 66 (2), 343-351, 2014 | 451 | 2014 |
| Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR AB Rosenkrantz, S Verma, P Choyke, SC Eberhardt, SE Eggener, ... The Journal of urology 196 (6), 1613-1618, 2016 | 411 | 2016 |
| Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales AB Rosenkrantz, S Kim, RP Lim, N Hindman, FM Deng, JS Babb, ... Radiology 269 (2), 482-492, 2013 | 315 | 2013 |
| Can urinary PCA3 supplement PSA in the early detection of prostate cancer? JT Wei, Z Feng, AW Partin, E Brown, I Thompson, L Sokoll, DW Chan, ... Journal of Clinical Oncology 32 (36), 4066-4072, 2014 | 312 | 2014 |
| Multiparametric MRI for prostate cancer diagnosis: current status and future directions A Stabile, F Giganti, AB Rosenkrantz, SS Taneja, G Villeirs, IS Gill, C Allen, ... Nature reviews urology 17 (1), 41-61, 2020 | 310 | 2020 |
| Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer AB Rosenkrantz, EE Sigmund, G Johnson, JS Babb, TC Mussi, ... Radiology 264 (1), 126-135, 2012 | 305 | 2012 |
| Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease-focused panel AC Westphalen, CE McCulloch, JM Anaokar, S Arora, NS Barashi, ... Radiology 296 (1), 76-84, 2020 | 274 | 2020 |
| Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy MG Kaag, RL O'Malley, P O'Malley, G Godoy, M Chen, MC Smaldone, ... European urology 58 (4), 581-587, 2010 | 271 | 2010 |
| Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing MA Bjurlin, HB Carter, P Schellhammer, MS Cookson, LG Gomella, ... The Journal of urology 189 (6), 2039-2046, 2013 | 269 | 2013 |
| Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI AB Rosenkrantz, SS Taneja American Journal of Roentgenology 202 (1), 109-120, 2014 | 236 | 2014 |
| Open versus laparoscopic versus robot-assisted laparoscopic prostatectomy: the European and US experience J Finkelstein, E Eckersberger, H Sadri, SS Taneja, H Lepor, B Djavan Reviews in urology 12 (1), 35, 2010 | 220 | 2010 |
| Focal therapy in prostate cancer—report from a consensus panel J De la Rosette, H Ahmed, J Barentsz, TB Johansen, M Brausi, ... Journal of Endourology 24 (5), 775-780, 2010 | 214 | 2010 |
| Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment MA Bjurlin, X Meng, J Le Nobin, JS Wysock, H Lepor, AB Rosenkrantz, ... The Journal of urology 192 (3), 648-658, 2014 | 209 | 2014 |
| Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial A Bahl, S Oudard, B Tombal, M Özgüroĝlu, S Hansen, I Kocak, G Gravis, ... Annals of Oncology 24 (9), 2402-2408, 2013 | 206 | 2013 |
